OpenEvidence
Series A in 2025
Information overload is an extreme challenge in medicine - the amount of medical research published annually is doubling every 5 years.
Such a rate of change makes it nearly impossible for the world’s physicians, medical researchers, and healthcare professionals to monitor and understand all the latest research literature and clinical evidence relevant to their work.
OpenEvidence tames this medical information firehose. We provide an artificial intelligence system to aggregate, synthesize, and visualize clinically relevant evidence in understandable, accessible formats that can be used to make more evidenced-based decisions, ease the cognitive load on clinicians, and improve patient outcomes.
OpenEvidence is trusted by over 7,000 care centers across the United States and used in over 170 countries worldwide.
Avelios Medical
Series A in 2025
Avelios Medical operates a modular clinic platform designed to enhance patient care by digitizing and optimizing clinic processes. The platform provides comprehensive support for healthcare staff, streamlining their daily tasks and fostering the integration of advanced technologies. By incorporating innovations such as artificial intelligence, big data, telemedicine, patient applications, and wearables, Avelios Medical aims to fundamentally transform healthcare delivery and research. This approach not only automates various operational processes but also enhances the overall efficiency and effectiveness of hospitals and clinics.
Maven Clinic
Series F in 2024
Maven Clinic is an on-demand digital care clinic focused on supporting mothers and families during conception, pregnancy, and the postpartum period. Founded in 2014 and headquartered in New York City, the clinic provides video appointments and private messaging with a network of women's and family health practitioners. Its comprehensive services cater to various needs, including IVF and egg-freezing tracks, pregnancy, postpartum, partner support, adoption, surrogacy, and loss. Additionally, Maven Clinic offers career coaching, support, and customized training for human resources managers. The company serves individuals, employers, and healthcare professionals, aiming to enhance family health and well-being through accessible digital care solutions.
Orasis Pharmaceuticals
Series D in 2024
Founded in 2015, Orasis Pharmaceuticals specializes in developing corrective eye drops for treating presbyopia. Its lead product, CSF-1, improves near visual acuity by pupil modulation, eliminating the need for reading glasses.
Summer Health
Series A in 2024
Summer Health facilitates convenient access to high-quality healthcare professionals via text messaging. It provides expert advice and reliable answers to users' health concerns.
Clinikally
Seed Round in 2023
Clinikally is India’s first integrated Telemedicine & E-Pharmacy platform specializing in Dermatology. It connects users with expert dermatologists within 30 minutes, providing personalized treatment plans and delivering Rx-grade products directly to their doorstep.
Maven Clinic
Series E in 2022
Maven Clinic is an on-demand digital care clinic focused on supporting mothers and families during conception, pregnancy, and the postpartum period. Founded in 2014 and headquartered in New York City, the clinic provides video appointments and private messaging with a network of women's and family health practitioners. Its comprehensive services cater to various needs, including IVF and egg-freezing tracks, pregnancy, postpartum, partner support, adoption, surrogacy, and loss. Additionally, Maven Clinic offers career coaching, support, and customized training for human resources managers. The company serves individuals, employers, and healthcare professionals, aiming to enhance family health and well-being through accessible digital care solutions.
Summer Health
Seed Round in 2022
Summer Health facilitates convenient access to high-quality healthcare professionals via text messaging. It provides expert advice and reliable answers to users' health concerns.
Medallion
Series C in 2022
Medallion is a San Francisco-based company founded in 2020 by Derek Lo, specializing in a network management platform tailored for the healthcare industry. The company offers an all-in-one solution for licensing, credentialing, and payer enrollment, aimed at simplifying the often cumbersome processes associated with healthcare paperwork. Its platform provides features such as primary source verification, continuing medical education tracking, and document management, enabling healthcare providers and telemedicine companies to minimize time spent on administrative tasks and focus more on patient care.
Us2.ai is a Singapore-based company that specializes in developing software and digital tools for echocardiography using artificial intelligence. The company's platform automates the manual process of measuring and interpreting echocardiograms, which are ultrasound images of the heart. This automation provides decision support tools designed to save doctors time, improve clinical trials for pharmaceutical companies, and enhance the detection of hard-to-diagnose cardiovascular conditions in hospitals. Us2.ai aims to simplify access to results of echo analysis and heart ultrasound through its online solutions.
Health Hero
Seed Round in 2022
Health Hero, Inc. is a wellness technology company that specializes in developing a custom wellness platform aimed at enhancing employee well-being across various industries globally. Founded in 2014 and headquartered in Tampa, Florida, the company offers a range of wellness options, including health risk assessments, cultural assessments, and biometric screenings, which can be accessed through mobile devices and computers. Health Hero's platform integrates gamification elements to engage employees by allowing them to earn points, badges, and rewards for completing tasks and reaching milestones. With a user reach exceeding five million and support for over 14,000 companies and communities, Health Hero effectively stores more than five billion health data points, positioning itself as a leader in the well-being sector.
Hebin Intelligence
Seed Round in 2022
Hebin Intelligence is an AI ultrasonic medical robot company providing remote ultrasound autonomous ultrasound diagnosis robots.
Athelas
Venture Round in 2022
Founded in 2002, Athelas develops and manufactures medical devices for remote patient monitoring. Its flagship product is an FDA-cleared blood diagnostic device that enables the detection of infections, inflammations, and malignancies. The company also offers sensors to monitor blood pressure, weight, glucose levels, and medication adherence.
Medallion
Series B in 2021
Medallion is a San Francisco-based company founded in 2020 by Derek Lo, specializing in a network management platform tailored for the healthcare industry. The company offers an all-in-one solution for licensing, credentialing, and payer enrollment, aimed at simplifying the often cumbersome processes associated with healthcare paperwork. Its platform provides features such as primary source verification, continuing medical education tracking, and document management, enabling healthcare providers and telemedicine companies to minimize time spent on administrative tasks and focus more on patient care.
Cambridge Epigenetix
Series D in 2021
Cambridge Epigenetix Limited is a bioscience company based in Babraham, United Kingdom, specializing in epigenetic tools that aim to transform medical diagnostics. Founded in 2012 as a spin-out from the University of Cambridge, the company is pioneering the clinical applications of epigenetics, particularly through its innovative TrueMethyl technology. This includes oxidative bisulfite sequencing, which allows for the precise sequencing of hydroxymethyl cytosine and methylcytosine at single-base resolution. Cambridge Epigenetix offers a range of products, such as TrueMethyl 6 and TrueMethyl 24 kits, designed for the quantitative measurement and analysis of these critical epigenetic markers. The company’s research highlights the significance of 5-hydroxymethylcytosine as a biomarker for various diseases, including colorectal cancer, and aims to simplify diagnostic processes to a simple blood draw. The firm collaborates with third-party vendors and sells its products directly to business customers both in the UK and internationally.
Maven Clinic
Series D in 2021
Maven Clinic is an on-demand digital care clinic focused on supporting mothers and families during conception, pregnancy, and the postpartum period. Founded in 2014 and headquartered in New York City, the clinic provides video appointments and private messaging with a network of women's and family health practitioners. Its comprehensive services cater to various needs, including IVF and egg-freezing tracks, pregnancy, postpartum, partner support, adoption, surrogacy, and loss. Additionally, Maven Clinic offers career coaching, support, and customized training for human resources managers. The company serves individuals, employers, and healthcare professionals, aiming to enhance family health and well-being through accessible digital care solutions.
DeepScribe
Seed Round in 2021
DeepScribe develops an AI-powered platform that automates medical note-taking for clinicians. Its solution captures and transcribes clinical conversations in real-time, extracts relevant information, and integrates notes into electronic health records (EHR). DeepScribe enables healthcare providers to focus on patient care while reducing documentation burden.
Expectful
Seed Round in 2021
Expectful is a digital health and wellness platform focused on supporting women throughout their reproductive journey, including preconception, pregnancy, and postpartum stages. The platform offers a range of resources such as guided meditations, mindfulness exercises, and expert advice tailored to the unique needs of expectant and new mothers. By providing a non-pharmacologic and accessible approach to mental health, Expectful aims to reduce prenatal and postpartum stress, enhancing the overall well-being of both mothers and infants. The app is designed to make meditation easy and effective, helping users navigate the physical, mental, and emotional challenges associated with motherhood.
Twin Health
Series B in 2020
Twin Health, Inc. is a precision health company that focuses on reversing diabetes and chronic diseases through its innovative health platform. Founded in 2018 and based in Mountain View, California, with additional offices in Chennai and Bengaluru, India, the company utilizes artificial intelligence and Internet-of-Things technologies to assess and restore metabolic health. Its platform analyzes complex biosignals from wearable sensors to predict metabolic outcomes and provide tailored treatment recommendations based on individual metabolic profiles. Twin Health has developed unique technology, with several patents granted and pending, that underpins its mission to normalize blood sugar levels and reduce reliance on medications.
Orasis Pharmaceuticals
Series C in 2020
Founded in 2015, Orasis Pharmaceuticals specializes in developing corrective eye drops for treating presbyopia. Its lead product, CSF-1, improves near visual acuity by pupil modulation, eliminating the need for reading glasses.
Practo is an online healthcare platform that facilitates various medical services for individuals and families. It allows users to assess health issues, find suitable doctors, book diagnostic tests, obtain medicines, and store health records, all in one place. The platform also enables patients to consult with doctors online, streamlining the appointment scheduling process and eliminating the need for physical visits to clinics. In addition to serving patients, Practo offers healthcare providers a comprehensive tool to enhance their online presence and engage more effectively with patients, thereby fostering deeper connections within the healthcare community.
Twin Health
Series A in 2020
Twin Health, Inc. is a precision health company that focuses on reversing diabetes and chronic diseases through its innovative health platform. Founded in 2018 and based in Mountain View, California, with additional offices in Chennai and Bengaluru, India, the company utilizes artificial intelligence and Internet-of-Things technologies to assess and restore metabolic health. Its platform analyzes complex biosignals from wearable sensors to predict metabolic outcomes and provide tailored treatment recommendations based on individual metabolic profiles. Twin Health has developed unique technology, with several patents granted and pending, that underpins its mission to normalize blood sugar levels and reduce reliance on medications.
Healthlane
Convertible Note in 2020
Healthlane is a healthcare technology company founded in 2020 and headquartered in Lagos, Nigeria, with additional offices in Yaounde, Cameroon, and San Francisco, California. It operates an online application that facilitates access to quality and affordable healthcare services. The platform allows users to track appointments at medical facilities, connect with certified doctors for virtual medical advice, and compile personal health data in one centralized location. Healthlane's services cater to various health needs, including pregnancy, vaccination, family planning, and lab results, making it easier for individuals to monitor their health effectively. Through its comprehensive approach, Healthlane aims to enhance healthcare accessibility and inform users about their medical options.
Maven Clinic
Series C in 2020
Maven Clinic is an on-demand digital care clinic focused on supporting mothers and families during conception, pregnancy, and the postpartum period. Founded in 2014 and headquartered in New York City, the clinic provides video appointments and private messaging with a network of women's and family health practitioners. Its comprehensive services cater to various needs, including IVF and egg-freezing tracks, pregnancy, postpartum, partner support, adoption, surrogacy, and loss. Additionally, Maven Clinic offers career coaching, support, and customized training for human resources managers. The company serves individuals, employers, and healthcare professionals, aiming to enhance family health and well-being through accessible digital care solutions.
Health Catalyst
Series F in 2019
Health Catalyst is a technology company that specializes in data and analytics solutions for healthcare organizations. The company offers a platform that organizes, normalizes, and links health-related data from various systems, making it accessible and searchable for all users, including those without technical expertise. Health Catalyst operates through two main segments: the Technology segment, which generates the majority of its revenue through cloud-based subscriptions, time-based licenses, and maintenance fees for its data platforms and analytics applications; and the Professional Services segment, which provides a range of services including analytics, implementation, strategic advisory, and outsourcing to help clients optimize their use of the technology. By integrating and analyzing healthcare data, Health Catalyst aims to enhance decision-making and improve outcomes in the healthcare sector.
Health Catalyst
Debt Financing in 2019
Health Catalyst is a technology company that specializes in data and analytics solutions for healthcare organizations. The company offers a platform that organizes, normalizes, and links health-related data from various systems, making it accessible and searchable for all users, including those without technical expertise. Health Catalyst operates through two main segments: the Technology segment, which generates the majority of its revenue through cloud-based subscriptions, time-based licenses, and maintenance fees for its data platforms and analytics applications; and the Professional Services segment, which provides a range of services including analytics, implementation, strategic advisory, and outsourcing to help clients optimize their use of the technology. By integrating and analyzing healthcare data, Health Catalyst aims to enhance decision-making and improve outcomes in the healthcare sector.
Founded in 2002, Athelas develops and manufactures medical devices for remote patient monitoring. Its flagship product is an FDA-cleared blood diagnostic device that enables the detection of infections, inflammations, and malignancies. The company also offers sensors to monitor blood pressure, weight, glucose levels, and medication adherence.
Genuity Science
Series C in 2018
Genuity Science is a company that specializes in clinco-omics data analysis solutions for researchers in the fields of central nervous system, cardiometabolic, and inflammatory diseases. The company provides a comprehensive global genomics platform that facilitates the study of biological data insights, offering services that include study design, genomic sequencing, data storage, interpretation, secondary analysis, and scalable analytics. By leveraging the human genome, Genuity Science aims to empower organizations to enhance patient health through advanced genomic insights and analysis.
Maven Clinic
Series B in 2018
Maven Clinic is an on-demand digital care clinic focused on supporting mothers and families during conception, pregnancy, and the postpartum period. Founded in 2014 and headquartered in New York City, the clinic provides video appointments and private messaging with a network of women's and family health practitioners. Its comprehensive services cater to various needs, including IVF and egg-freezing tracks, pregnancy, postpartum, partner support, adoption, surrogacy, and loss. Additionally, Maven Clinic offers career coaching, support, and customized training for human resources managers. The company serves individuals, employers, and healthcare professionals, aiming to enhance family health and well-being through accessible digital care solutions.
Cambridge Epigenetix
Series C in 2018
Cambridge Epigenetix Limited is a bioscience company based in Babraham, United Kingdom, specializing in epigenetic tools that aim to transform medical diagnostics. Founded in 2012 as a spin-out from the University of Cambridge, the company is pioneering the clinical applications of epigenetics, particularly through its innovative TrueMethyl technology. This includes oxidative bisulfite sequencing, which allows for the precise sequencing of hydroxymethyl cytosine and methylcytosine at single-base resolution. Cambridge Epigenetix offers a range of products, such as TrueMethyl 6 and TrueMethyl 24 kits, designed for the quantitative measurement and analysis of these critical epigenetic markers. The company’s research highlights the significance of 5-hydroxymethylcytosine as a biomarker for various diseases, including colorectal cancer, and aims to simplify diagnostic processes to a simple blood draw. The firm collaborates with third-party vendors and sells its products directly to business customers both in the UK and internationally.
Orasis Pharmaceuticals
Series B in 2018
Founded in 2015, Orasis Pharmaceuticals specializes in developing corrective eye drops for treating presbyopia. Its lead product, CSF-1, improves near visual acuity by pupil modulation, eliminating the need for reading glasses.
VoxelCloud
Series A in 2017
VoxelCloud Inc. is a technology company specializing in cloud computing and artificial intelligence solutions aimed at enhancing the interpretation of medical images and clinical data. Founded in 2015 and headquartered in Los Angeles, California, VoxelCloud develops automated medical image analysis services that assist healthcare practitioners in diagnosing conditions such as lung cancer, diabetic retinopathy, coronary heart disease, and liver disease. Utilizing proprietary algorithms and deep learning techniques, the company provides accurate and timely insights, transforming clinical workflows and enabling evidence-based decision-making. In addition to its Los Angeles headquarters, VoxelCloud maintains offices in Shanghai and Suzhou, China, and has a satellite research and development team in Phoenix, further supporting its commitment to advancing healthcare through innovative technology.
Infervision
Series B in 2017
Infervision is a Beijing-based artificial intelligence company specializing in medical imaging diagnosis through advanced deep learning technology and computer vision. The company develops innovative products aimed at enhancing the efficiency and accuracy of cancer diagnosis. Infervision's efforts led to the creation of the world's first artificial intelligence precise healthcare platform, along with intelligent X-ray and CT assisted diagnosis products, which are currently undergoing trials in several prestigious hospitals across China. The company is deeply committed to academic collaboration, partnering with leading institutions in Chinese Radiology to integrate medical science with technology. Infervision has established partnerships with nearly 20 top-tier hospitals, facilitating the seamless integration of medical data, technology, and application scenarios. This unique approach has enabled Infervision to build a comprehensive artificial intelligence computing platform and a precise healthcare intelligence system that supports medical professionals in delivering better diagnostic outcomes with increased efficiency and reduced costs.
Genuity Science
Series B in 2017
Genuity Science is a company that specializes in clinco-omics data analysis solutions for researchers in the fields of central nervous system, cardiometabolic, and inflammatory diseases. The company provides a comprehensive global genomics platform that facilitates the study of biological data insights, offering services that include study design, genomic sequencing, data storage, interpretation, secondary analysis, and scalable analytics. By leveraging the human genome, Genuity Science aims to empower organizations to enhance patient health through advanced genomic insights and analysis.
Athelas
Seed Round in 2017
Founded in 2002, Athelas develops and manufactures medical devices for remote patient monitoring. Its flagship product is an FDA-cleared blood diagnostic device that enables the detection of infections, inflammations, and malignancies. The company also offers sensors to monitor blood pressure, weight, glucose levels, and medication adherence.
VoxelCloud
Series A in 2017
VoxelCloud Inc. is a technology company specializing in cloud computing and artificial intelligence solutions aimed at enhancing the interpretation of medical images and clinical data. Founded in 2015 and headquartered in Los Angeles, California, VoxelCloud develops automated medical image analysis services that assist healthcare practitioners in diagnosing conditions such as lung cancer, diabetic retinopathy, coronary heart disease, and liver disease. Utilizing proprietary algorithms and deep learning techniques, the company provides accurate and timely insights, transforming clinical workflows and enabling evidence-based decision-making. In addition to its Los Angeles headquarters, VoxelCloud maintains offices in Shanghai and Suzhou, China, and has a satellite research and development team in Phoenix, further supporting its commitment to advancing healthcare through innovative technology.
Guardant Health
Series E in 2017
Guardant Health is a precision oncology company specializing in blood tests and analytics. It provides liquid biopsy tests like Guardant360 for advanced cancer detection, GuardantOMNI for broader gene panels, LUNAR-1 for minimal residual disease detection, and LUNAR-2 for early cancer detection. The company also offers development services to biopharmaceutical companies.
VoxelCloud
Seed Round in 2016
VoxelCloud Inc. is a technology company specializing in cloud computing and artificial intelligence solutions aimed at enhancing the interpretation of medical images and clinical data. Founded in 2015 and headquartered in Los Angeles, California, VoxelCloud develops automated medical image analysis services that assist healthcare practitioners in diagnosing conditions such as lung cancer, diabetic retinopathy, coronary heart disease, and liver disease. Utilizing proprietary algorithms and deep learning techniques, the company provides accurate and timely insights, transforming clinical workflows and enabling evidence-based decision-making. In addition to its Los Angeles headquarters, VoxelCloud maintains offices in Shanghai and Suzhou, China, and has a satellite research and development team in Phoenix, further supporting its commitment to advancing healthcare through innovative technology.
Cambridge Epigenetix
Series B in 2016
Cambridge Epigenetix Limited is a bioscience company based in Babraham, United Kingdom, specializing in epigenetic tools that aim to transform medical diagnostics. Founded in 2012 as a spin-out from the University of Cambridge, the company is pioneering the clinical applications of epigenetics, particularly through its innovative TrueMethyl technology. This includes oxidative bisulfite sequencing, which allows for the precise sequencing of hydroxymethyl cytosine and methylcytosine at single-base resolution. Cambridge Epigenetix offers a range of products, such as TrueMethyl 6 and TrueMethyl 24 kits, designed for the quantitative measurement and analysis of these critical epigenetic markers. The company’s research highlights the significance of 5-hydroxymethylcytosine as a biomarker for various diseases, including colorectal cancer, and aims to simplify diagnostic processes to a simple blood draw. The firm collaborates with third-party vendors and sells its products directly to business customers both in the UK and internationally.
Guardant Health
Series D in 2016
Guardant Health is a precision oncology company specializing in blood tests and analytics. It provides liquid biopsy tests like Guardant360 for advanced cancer detection, GuardantOMNI for broader gene panels, LUNAR-1 for minimal residual disease detection, and LUNAR-2 for early cancer detection. The company also offers development services to biopharmaceutical companies.
Health Catalyst
Series D in 2015
Health Catalyst is a technology company that specializes in data and analytics solutions for healthcare organizations. The company offers a platform that organizes, normalizes, and links health-related data from various systems, making it accessible and searchable for all users, including those without technical expertise. Health Catalyst operates through two main segments: the Technology segment, which generates the majority of its revenue through cloud-based subscriptions, time-based licenses, and maintenance fees for its data platforms and analytics applications; and the Professional Services segment, which provides a range of services including analytics, implementation, strategic advisory, and outsourcing to help clients optimize their use of the technology. By integrating and analyzing healthcare data, Health Catalyst aims to enhance decision-making and improve outcomes in the healthcare sector.
Lifecode, Inc. is a molecular diagnostics company based in Foster City, California, specializing in next-generation sequencing (NGS) technology. The company develops a range of NGS-based cancer assays, including its flagship product, the Lifecode Pan Cancer Somatic Panel, which is designed for use in various metastatic and rare cancers, as well as for patients seeking clinical trials. Lifecode focuses on translating complex genomic and therapeutic data into actionable insights for healthcare providers, patients, and payers. The company's team comprises experts in data science, software engineering, computational biology, bioinformatics, machine learning, molecular biology, and pathology, enabling it to bridge the gap between advanced sequencing technology and clinical application. Lifecode was previously known as Silicon Valley Biosystems, Inc. and rebranded in 2015. As of early 2016, it operates as a subsidiary of MedGenome Labs Private Ltd.
Guardant Health
Series C in 2015
Guardant Health is a precision oncology company specializing in blood tests and analytics. It provides liquid biopsy tests like Guardant360 for advanced cancer detection, GuardantOMNI for broader gene panels, LUNAR-1 for minimal residual disease detection, and LUNAR-2 for early cancer detection. The company also offers development services to biopharmaceutical companies.
Guardant Health
Series B in 2014
Guardant Health is a precision oncology company specializing in blood tests and analytics. It provides liquid biopsy tests like Guardant360 for advanced cancer detection, GuardantOMNI for broader gene panels, LUNAR-1 for minimal residual disease detection, and LUNAR-2 for early cancer detection. The company also offers development services to biopharmaceutical companies.
Guardant Health
Series A in 2014
Guardant Health is a precision oncology company specializing in blood tests and analytics. It provides liquid biopsy tests like Guardant360 for advanced cancer detection, GuardantOMNI for broader gene panels, LUNAR-1 for minimal residual disease detection, and LUNAR-2 for early cancer detection. The company also offers development services to biopharmaceutical companies.
Health Catalyst
Series C in 2014
Health Catalyst is a technology company that specializes in data and analytics solutions for healthcare organizations. The company offers a platform that organizes, normalizes, and links health-related data from various systems, making it accessible and searchable for all users, including those without technical expertise. Health Catalyst operates through two main segments: the Technology segment, which generates the majority of its revenue through cloud-based subscriptions, time-based licenses, and maintenance fees for its data platforms and analytics applications; and the Professional Services segment, which provides a range of services including analytics, implementation, strategic advisory, and outsourcing to help clients optimize their use of the technology. By integrating and analyzing healthcare data, Health Catalyst aims to enhance decision-making and improve outcomes in the healthcare sector.
Angel Medical Group
Series B in 2014
Angel Medical Group (安琪儿医疗控股集团) is an investment group focused on integrating superior medical resources in Chinese mainland, investing in high-end obstetrics medical institutions, and dealing with brand chain operation.
Angel Medical Group is headquartered in Chengdu, in accordance with the international medical business philosophy. Its subordinate hospital is established referring to international JCI Standard, which is an obstetrics and gynecology hospital integrating medical treatment, scientific research, precaution, health care and recovery, aiming at making a model of high-end maternity health service. Chengdu Angel Hospital for Gynaecology and Obstetrics is the high-end hospital for gynecology and obstetrics under the group, and has been recognized by industry and society.
IPG, founded in 2004 and headquartered in Alpharetta, Georgia, specializes in surgical cost management services aimed at reducing expenses associated with surgical and implant procedures. The company collaborates with health plans, providers, surgical facilities, device manufacturers, and patients nationwide to enhance quality and reduce costs through effective site of care optimization and device selection. By developing market-based solutions in the implantable Device Benefit Management space, IPG enables healthcare providers, manufacturers, and physicians to lower out-of-pocket costs for patients, ultimately delivering tangible value in the healthcare system.
Health Catalyst
Series B in 2013
Health Catalyst is a technology company that specializes in data and analytics solutions for healthcare organizations. The company offers a platform that organizes, normalizes, and links health-related data from various systems, making it accessible and searchable for all users, including those without technical expertise. Health Catalyst operates through two main segments: the Technology segment, which generates the majority of its revenue through cloud-based subscriptions, time-based licenses, and maintenance fees for its data platforms and analytics applications; and the Professional Services segment, which provides a range of services including analytics, implementation, strategic advisory, and outsourcing to help clients optimize their use of the technology. By integrating and analyzing healthcare data, Health Catalyst aims to enhance decision-making and improve outcomes in the healthcare sector.
EndoChoice
Venture Round in 2013
EndoChoice is a medical device company specializing in the development and commercialization of technologies for gastrointestinal (GI) care. Founded in 2008 and headquartered in Alpharetta, Georgia, the company offers a range of products that include single-use devices, diagnostics, infection control products, and endoscopic imaging systems tailored for GI specialists. One of its notable innovations is the Full Spectrum Endoscopy™ System, which features colonoscopes and gastroscopes equipped with multiple imagers, allowing for a wider field of view compared to traditional endoscopes. This technology has demonstrated its efficacy by detecting significantly more polyps during colonoscopy procedures. EndoChoice serves over 2,000 customers in the United States and collaborates with 34 distribution partners globally. The company was recognized by Inc. Magazine as one of the fastest-growing companies in the U.S. for four consecutive years prior to its acquisition by Boston Scientific in 2016.
Health Catalyst
Series A in 2011
Health Catalyst is a technology company that specializes in data and analytics solutions for healthcare organizations. The company offers a platform that organizes, normalizes, and links health-related data from various systems, making it accessible and searchable for all users, including those without technical expertise. Health Catalyst operates through two main segments: the Technology segment, which generates the majority of its revenue through cloud-based subscriptions, time-based licenses, and maintenance fees for its data platforms and analytics applications; and the Professional Services segment, which provides a range of services including analytics, implementation, strategic advisory, and outsourcing to help clients optimize their use of the technology. By integrating and analyzing healthcare data, Health Catalyst aims to enhance decision-making and improve outcomes in the healthcare sector.
Lifecode
Venture Round in 2011
Lifecode, Inc. is a molecular diagnostics company based in Foster City, California, specializing in next-generation sequencing (NGS) technology. The company develops a range of NGS-based cancer assays, including its flagship product, the Lifecode Pan Cancer Somatic Panel, which is designed for use in various metastatic and rare cancers, as well as for patients seeking clinical trials. Lifecode focuses on translating complex genomic and therapeutic data into actionable insights for healthcare providers, patients, and payers. The company's team comprises experts in data science, software engineering, computational biology, bioinformatics, machine learning, molecular biology, and pathology, enabling it to bridge the gap between advanced sequencing technology and clinical application. Lifecode was previously known as Silicon Valley Biosystems, Inc. and rebranded in 2015. As of early 2016, it operates as a subsidiary of MedGenome Labs Private Ltd.
MedExpress Urgent Care
Private Equity Round in 2010
MedExpress operates multiple full-service, walk-in urgent care facilities offering timely medical treatment to non-life threatening injuries and illnesses in Florida, Pennsylvania, Delaware, New Jersey, Tennessee, Maryland and West Virginia. No appointments are necessary, most types of insurance are accepted (but not required), and centers are open 12 hours a day, 7 days week. MedExpress facilities are always staffed by a physician and supported by a full medical team. Founded in 2001, MedExpress is headquartered in Morgantown, West Virginia.
Jiujiuweikang
Venture Round in 2010
Jiujiuweikang is an e-commerce company that aims to provide health related technology services. It has several hundred professional health consultants and call centers with systematic and effective management software, together with numerous members. Jiujiuweikang is currently the biggest health technology service company in Shanghai.
Jiujiuweikang was founded by Shanghai Xifeng Electronic Commerce, and is funded by foreign capital.
Beijingyicheng
Series A in 2010
Yicheng Bioelectronics Technology is a Chinese enterprise focused on the manufacture of rapid medical detection solutions.
Founded in 1993, Beijing Yicheng’s product lineup include glucometers, whole blood lactate analyzers, whole blood ketone body analyzers, whole blood cholesterol analyzers, renal damage detection cards, microchip systems for glycosylated hemoglobin, albumin antibodies with detection kits, hemoglobin antibodies with detection kits, glycosylated hemoglobin antibodies with detection kits, and more.
IPG, founded in 2004 and headquartered in Alpharetta, Georgia, specializes in surgical cost management services aimed at reducing expenses associated with surgical and implant procedures. The company collaborates with health plans, providers, surgical facilities, device manufacturers, and patients nationwide to enhance quality and reduce costs through effective site of care optimization and device selection. By developing market-based solutions in the implantable Device Benefit Management space, IPG enables healthcare providers, manufacturers, and physicians to lower out-of-pocket costs for patients, ultimately delivering tangible value in the healthcare system.
eCardio Diagnostics, headquartered in Houston, Texas, specializes in remote cardiac monitoring products and services aimed at enhancing the diagnosis and management of arrhythmia. Since its inception in 2004, eCardio has collaborated with thousands of physicians and patients, focusing on improving patient care for those with heart rhythm disorders. The company offers a range of innovative clinical services and advanced devices that streamline the arrhythmia monitoring process. This approach not only increases patient compliance but also reduces the time needed for physicians to diagnose arrhythmias, ultimately resulting in more precise and timely patient management.
HealthCentral
Post in 2008
HealthCentral Corporation operates a digital health media platform, primarily serving patients with chronic illnesses and healthcare professionals. Established in 1999, the company owns and manages over 30 condition-specific, wellness, and general health websites, offering a comprehensive range of resources including news, videos, patient communities, and reputable health publications. HealthCentral's platform covers a wide array of health conditions, empowering users to navigate their healthcare journey with informed decisions. The company also produces the nationally syndicated television show, "Medical Breakthroughs with Dr. Dean Edell." Headquartered in Arlington, Virginia, HealthCentral competes with prominent players such as WebMD and About.com Health.
Aragen Life Sciences
Venture Round in 2007
Aragen Life Sciences is a prominent discovery research and development organization in Asia, providing a comprehensive range of services across the R&D and manufacturing value chain. The company specializes in drug discovery, clinical development, contract manufacturing, formulation, and informatics, catering to the needs of healthcare institutions and other sectors. With over a decade of experience in delivering innovative drug discovery and development services, Aragen is equipped with a team of skilled scientists and advanced technologies that enable them to achieve exceptional results for their clients. The organization employs approximately 2,400 professionals and serves a diverse global customer base, including prominent players in pharmaceuticals, agrochemicals, electronics, biotechnology, and academia. Aragen Life Sciences is recognized for its commitment to quality, speed, and affordability, consistently meeting and exceeding customer expectations in their research endeavors.
Navigenics
Venture Round in 2007
Navigenics, Inc. specializes in personalized genetics testing and health counseling services aimed at educating individuals and their physicians about genetic predispositions. The company provides genetic information and analysis to empower clients to take proactive measures to prevent disease, facilitate early diagnosis, and effectively manage health conditions. Navigenics delivers its services through a network of medical centers and physicians, as well as employer wellness programs at leading corporations. By motivating individuals to act on their genetic insights, Navigenics seeks to enhance overall health outcomes and reduce the impact of potential diseases.
Ameritox
Venture Round in 2007
Ameritox is a U.S.-based company established in 1996 that specializes in pain medication monitoring services. It provides laboratory services and practice management tools designed to assist clinicians in coordinating and optimizing care for patients suffering from chronic pain. In addition to its core offerings, Ameritox supports healthcare providers with expert guidance and resources, facilitating improved patient management. The company is recognized for its innovative research programs, collaborating with academic institutions and pain centers to advance the field of pain medication monitoring.